Abstract
Hepatocellular carcinoma (HCC) is one of the most common human cancers all over the world. Increasing evidences have demonstrated that long noncoding RNAs (lncRNAs) play important roles in malignant transformation, tumor growth and metastasis in HCC. Among lncRNAs, ultraconserved RNAs (ucRNAs) containing an ultraconserved region have been report to contribute to human cancers. lncRNA ultraconserved element 338 (uc.338) was first found to be upregulated in HCC and promote cell growth. However, the exact mechanism by which uc.338 modulates cell growth remains unclear. In the present study, we demonstrated that uc.338 promotes HCC cell proliferation and induces cell cycle progression. RNA-immunoprecipitation and RNA pull-down assays showed that uc.338 associated with BMI1. We found that uc.338 promotes HCC cell proliferation and induces cell cycle progression through association with BMI1. uc.338 also modulated the transcription of CDKN1A. The oncogenic activity of uc.338 is partially due to its repression of p21. uc.338 may be a potential target for HCC therapy.
Similar content being viewed by others
References
Kimhofer T, Fye H, Taylor-Robinson S, Thursz M, Holmes E. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer. 2015;112(7):1141–56. doi:10.1038/bjc.2015.38.
Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: a comprehensive review. World J Hepatol. 2015;7(26):2648–63. doi:10.4254/wjh.v7.i26.2648.
Rosa A, Ballarino M. Long Noncoding RNA Regulation of Pluripotency. Stem Cells Int. 2016;2016:1797692. doi:10.1155/2016/1797692.
Briggs JA, Wolvetang EJ, Mattick JS, Rinn JL, Barry G. Mechanisms of long non-coding RNAs in mammalian nervous system development, plasticity, disease, and evolution. Neuron. 2015;88(5):861–77. doi:10.1016/j.neuron.2015.09.045.
Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell. 2014;26(3):344–57. doi:10.1016/j.ccr.2014.07.009.
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25(5):666–81. doi:10.1016/j.ccr.2014.03.010.
Davidovich C, Cech TR. The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2. RNA. 2015;21(12):2007–22. doi:10.1261/rna.053918.115.
Silva A, Bullock M, Calin G. The clinical relevance of long non-coding RNAs in cancer. Cancers. 2015;7(4):2169–82. doi:10.3390/cancers7040884.
Kim TK, Shiekhattar R. Architectural and functional commonalities between enhancers and promoters. Cell. 2015;162(5):948–59. doi:10.1016/j.cell.2015.08.008.
De Grassi A, Segala C, Iannelli F, Volorio S, Bertario L, Radice P et al. Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instability. PLoS Biol. 2010;8(1):e1000275. doi:10.1371/journal.pbio.1000275.
Peng JC, Shen J, Ran ZH. Transcribed ultraconserved region in human cancers. RNA Biol. 2013;10(12):1771–7. doi:10.4161/rna.26995.
Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci USA. 2011;108(2):786–91. doi:10.1073/pnas.1011098108.
Cao C, Sun J, Zhang D, Guo X, Xie L, Li X et al. The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of beta-catenin in HCC cells. Gastroenterology. 2015;148(2):415–26. doi:10.1053/j.gastro.2014.10.012.
Zhang Y, Li Z, Zhang Y, Zhong Q, Chen Q, Zhang L. Molecular mechanism of HEIH and HULC in the proliferation and invasion of hepatoma cells. Int J Clin Exp Med. 2015;8(8):12956–62.
Ehedego H, Boekschoten MV, Hu W, Doler C, Haybaeck J, Gabetaler N et al. p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis. Cancer Res. 2015;75(6):1144–55. doi:10.1158/0008-5472.CAN-14-1356.
Deng W, Zhou Y, Tiwari AF, Su H, Yang J, Zhu D et al. p21/Cyclin E pathway modulates anticlastogenic function of Bmi-1 in cancer cells. Int J Cancer. 2015;136(6):1361–70. doi:10.1002/ijc.29114.
Rizki G, Boyer LA. Lncing epigenetic control of transcription to cardiovascular development and disease. Circulation Res. 2015;117(2):192–206. doi:10.1161/CIRCRESAHA.117.304156.
Kindrat I, Tryndyak V, de Conti A, Shpyleva S, Mudalige TK, Kobets T et al. MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis. Oncotarget. 2015. doi:10.18632/oncotarget.6004.
Kogure T, Yan IK, Lin WL, Patel T. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer. 2013;4(7–8):261–72. doi:10.1177/1947601913499020.
Guo W, Liu S, Cheng Y, Lu L, Shi J, Xu G et al. ICAM-1-related non-coding RNA in cancer stem cells maintains ICAM-1 expression in hepatocellular carcinoma. Clin Cancer Res. 2016. doi:10.1158/1078-0432.CCR-14-3106.
Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S et al. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer. 2013;12:13. doi:10.1186/1476-4598-12-13.
Satyanarayana A, Hilton MB, Kaldis P. p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Mol Biol Cell. 2008;19(1):65–77. doi:10.1091/mbc.E07-06-0525.
Bashir T, Pagano M. Cdk1: the dominant sibling of Cdk2. Nat Cell Biol. 2005;7(8):779–81. doi:10.1038/ncb0805-779.
Lee SH, Um SJ, Kim EJ. CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1. Cancer Lett. 2013;335(2):397–403. doi:10.1016/j.canlet.2013.02.051.
Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res. 2011;9(4):418–29. doi:10.1158/1541-7786.MCR-10-0511.
Balasubramanian S, Adhikary G, Eckert RL. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis. 2010;31(3):496–503. doi:10.1093/carcin/bgp314.
Liu K, Sun B, Zhao X, Wang X, Li Y, Qiu Z et al. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma. Int J Mol Med. 2015;36(3):783–91. doi:10.3892/ijmm.2015.2293.
Xu CR, Lee S, Ho C, Bommi P, Huang SA, Cheung ST et al. Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis. Mol Cancer Res. 2009;7(12):1937–45. doi:10.1158/1541-7786.MCR-09-0333.
Aguilo F, Zhou MM, Walsh MJ. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARFINK4a expression. Cancer Res. 2011;71(16):5365–9. doi:10.1158/0008-5472.CAN-10-4379.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Bo, C., Li, N., Li, X. et al. Long noncoding RNA uc.338 promotes cell proliferation through association with BMI1 in hepatocellular carcinoma. Human Cell 29, 141–147 (2016). https://doi.org/10.1007/s13577-016-0140-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13577-016-0140-z